IP Library Assignment 031086/0431
Patent Assignment
Reel/Frame 031086/0431

Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca

Recorded: 2013-08-26 Pages: 4
Assignor
AMYLIN PHARMACEUTICALS, LLC
Executed: 2012-09-19
Assignee
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, WILMINGTON, DELAWARE, 19803
Covered Property (1)
Treatment of Hibernating Myocardium with an Exendin Peptide
Patent: 8,551,947 →
Application: 12/945,702 →
Publication: US 2012/0302501
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Nov 8, 2011
From: AMYLIN PHARMACEUTICALS, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 027192/0334 →
Release of Security Interest Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Change of Name Aug 26, 2013
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 031086/0388 →